Abstract:Background: Viral resistance to existing inhibitors and the time-dependent effectiveness of neuraminidase inhibitors have limited the number of antivirals that can be used for prophylaxis and therapeutic treatment of severe influenza infection. Thus, there is an urgent need to develop new drugs to prevent and treat influenza infection. Objective: The aim of this study was to design and synthesize a novel series of 2-ureidonicotinamide derivatives, and evaluate their anti-IAV activities. Furthermore, we predicted the abilities of these compounds inhibiting PA-PB1 subunit and forecasted the docking poses of these compounds with RNA polymerase protein (PDB ID 3CM8). Method: The novel designed compounds were synthesized using classical methods of organic chemistry and tested in vitro for their abilities inhibiting RNP and against influenza A virus. In addition, the 23 synthesized molecules were subjected to the generated pharmacophore Hypo1 to forecast the activity target PA-PB1 subunit of RNA polymerase. The ADMET pharmacokinetic parameters were calculated by the ADMET modules in Discovery Studio 2016. The docking results helped us to demonstrate the possible interactions between these compounds with 3CM8. Results: The synthesized 2-ureidonicotinamide derivatives were characterized as potent anti-influenza inhibitors. The target compounds 7b and 7c demonstrated significant antiviral activities, and could be considered as novel lead compounds of antiviral inhibitors. In addition, compound 7b revealed suitable ADME properties expressed, and might be a significant RNA polymerase inhibitor targeting PA-PB1 subunit based on the predictable results and the docking results. Conclusion: This study revealed a novel series of compounds that might be useful in the search for an effective drug against influenza virus.

Synthesis and anti-influenza virus activity of polyoxometalates containing amantadine

Anti-influenza A(H5N1) virus activities of a novel polyoxometalate in vitro and in vivo

Synthesis And Antiviral Activities Of Amide Derivatives Containing The Alpha-Aminophosphonate Moiety

Synthesis, structural characterization and biological activity of polyoxometallate-containing protonated amantadine as a cation

Synthesis and Antiviral Activities of Amide Derivatives Containing the α-Aminophosphonate Moiety

Synthesis, Structure Activity Relationship and in Vitro Anti-Influenza Virus Activity of Novel Polyphenol-Pentacyclic Triterpene Conjugates.

Design, Synthesis and Anti-H5n1 Activities of Amantadine Derivatives

Novel Α,β-Unsaturated Amide Derivatives Bearing Α-Amino Phosphonate Moiety As Potential Antiviral Agents

Synthesis, Characterization and Antiviral Activity Against Influenza Virus of a Series of Novel Manganese-Substituted Rare Earth Borotungstates Heteropolyoxometalates.

Synthesis, evaluation and structure-activity relationship studies of pterodontic acid acylated derivatives with anti-flu A virus (H1N1) activity in vitro

Nine-valent oleanolic acid conjugates as potent inhibitors blocking the entry of influenza A virus

Design, Synthesis and Biological Evaluation of Amino Acids-Oleanolic Acid Conjugates As Influenza Virus Inhibitors.

Novel Alpha, Beta-Unsaturated Amide Derivatives Bearing Alpha-Amino Phosphonate Moiety As Potential Antiviral Agents

Design,Synthesis and Anti-influenza Activities of Novel Neuraminidase Inhibitors

Structure-Based Design, Synthesis and Anti-Influenza A Virus Activities of Substituted Phenyl-Coupled Heterocyclic Ethylamide Derivatives

Design, synthesis, and biological activity of a novel series of 2-ureidonicotinamide derivatives against influenza A virus

Polyvalent Effect Enhances Anti-influenza Virus Activity

Synthesis, Structure Activity Relationship and Anti-influenza A Virus Evaluation of Oleanolic Acid-Linear Amino Derivatives

Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy

Synthesis and Biological Activity of Ethyl 4-Acetamido-3-(4-arylthiazol-2-yl-amino)benzoate

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents